SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-305262
Filing Date
2022-12-15
Accepted
2022-12-15 06:11:46
Documents
12
Period of Report
2022-12-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d436088d8k.htm   iXBRL 8-K 33982
  Complete submission text file 0001193125-22-305262.txt   157915

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20221214.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20221214_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20221214_pre.xml EX-101.PRE 11257
6 EXTRACTED XBRL INSTANCE DOCUMENT d436088d8k_htm.xml XML 3398
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 221463601
SIC: 2834 Pharmaceutical Preparations